Search
Search Results
##search.searchResults.foundPlural##
-
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2369PDF: 893HTML: 492 -
THE GUT MICROBIOTA AND IMMUNE SYSTEM RELATIONSHIP IN HUMAN GRAFT-VERSUS-HOST DISEASE
6206PDF: 2057HTML: 13979Untitled: 185figure: 167 -
ROLE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
1981PDF: 774HTML: 1027 -
Is laboratory monitoring useful in DOACs management?
798PDF: 779HTML: 99 -
-
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1129PDF: 804HTML: 2165Figue 1: 163 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2477PDF: 924HTML: 2218 -
EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome
707PDF: 425HTML: 73 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7743PDF: 4018HTML: 7304 -
-
COAGULOPATHY IN BETA-THALASSEMIA: CURRENT UNDERSTANDING AND FUTURE PERSPECTIVES
1046PDF: 472HTML: 8139 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2343PDF: 980HTML: 1635Fig 1: 169Tab I: 195Cover Letter: 187 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1652PDF: 785HTML: 924cover letter: 252 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1766PDF: 785HTML: 10213Figures 1,2,3: 158 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1370PDF: 906HTML: 301 -
IMMUNOLOGY OF TUBERCULOSIS
5161PDF: 1969HTML: 7254Untitled: 188 -
AGE AT DIAGNOSIS OF SICKLE CELL ANAEMIA IN LAGOS, NIGERIA
1932PDF: 874HTML: 1852 -
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA: NON-RANDOMIZED STUDY WITH A MAXIMUM FOLLOW-UP OF MORE THAN 22 YEARS
1503PDF: 886HTML: 1937Figure: 158Tables: 175ALL revision 1: 180response to reviewer: 166 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1720PDF: 548HTML: 266 -
High level of HBV DNA virus in the breast milk seems not to contraindicate breastfeeding
2133PDF: 800HTML: 937Untitled: 255 -
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
1553PDF: 780HTML: 144 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2199PDF: 839HTML: 2068 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3184PDF: 1204HTML: 8090







